

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 2,5mg | 360 pills | A$1.10 | A$497.70 A$398.16 Popular | |
| 2,5mg | 180 pills | A$1.19 | A$267.77 A$214.22 | |
| 2,5mg | 120 pills | A$1.28 | A$192.03 A$153.62 | |
| 2,5mg | 90 pills | A$1.38 | A$156.86 A$125.49 | |
| 2,5mg | 60 pills | A$1.51 | A$113.58 A$90.87 | |
| 2,5mg | 30 pills | A$1.80 | A$67.60 A$54.08 | |
| 5mg | 360 pills | A$0.97 | A$438.19 A$350.55 Best Price | |
| 5mg | 180 pills | A$1.13 | A$254.24 A$203.40 | |
| 5mg | 120 pills | A$1.19 | A$178.50 A$142.80 | |
| 5mg | 90 pills | A$1.26 | A$140.63 A$112.51 | |
| 5mg | 60 pills | A$1.30 | A$97.35 A$77.88 | |
| 5mg | 30 pills | A$1.51 | A$56.78 A$45.42 |
Disclaimer: This information is for general patient education and does not replace medical advice. For personalised guidance, please consult your doctor or pharmacist.
Micronase is the brand name used for the medicine glyburide, which is also known as glibenclamide in some places. In Australia, Micronase may be available in line with local regulatory rules and may require a prescription depending on current rules. The medicine belongs to a group called sulfonylureas. It helps to lower blood glucose (sugar) levels in adults with type 2 diabetes when diet and exercise alone do not achieve adequate control.
Glyburide works by stimulating the pancreas to release more insulin. Insulin is the hormone that helps glucose move from the blood into the body’s cells where it can be used for energy. This action reduces high blood sugar after meals and can help improve overall blood glucose control when used alongside healthy eating and physical activity.
Micronase is usually taken by mouth in tablet form. The tablet should be swallowed whole with a glass of water. In Australia, the product information and dose schedule are tailored to adult patients, and the medicine is prescribed by a clinician who weighs up benefits and risks for each person. Do not take Micronase if you have not been advised by a healthcare professional to do so.
People who have never taken glyburide before or who have never been diagnosed with type 2 diabetes should receive careful medical assessment before starting Micronase. The medicine is not a cure for diabetes; it is a treatment that helps manage blood sugar levels as part of a broader diabetes care plan. If you have questions about whether Micronase is right for you, ask your doctor or pharmacist for information based on your health history.
In addition to adults, healthcare professionals will consider other factors such as kidney or liver function, other medicines you take, and any history of low blood sugar. This helps determine whether Micronase is suitable and safe for you in Australia at this time.
Micronase is used to improve blood sugar control in adults with type 2 diabetes when lifestyle changes alone are not enough. It is intended to be part of a complete treatment plan that includes a healthy diet, regular exercise, and weight management as advised by your clinician. It is not designed for use in type 1 diabetes or for the treatment of diabetic ketoacidosis.
In some cases, Micronase may be prescribed together with other diabetes medicines, including metformin or insulin, to achieve better blood glucose control. The prescribing clinician will determine the appropriate combination based on how your body responds and any other health conditions you have.
This medicine does not replace the need for a healthy lifestyle. Ongoing monitoring of blood sugar levels is important, and your healthcare team may adjust your treatment plan over time as needed. If your blood sugar remains high despite taking Micronase, or if you experience very low blood sugar, you should seek medical advice promptly.
Your clinician may periodically reassess the use of Micronase. If there is a change in your health status, such as new illnesses, pregnancy, or changes in diet or physical activity, inform your doctor. They may adjust the treatment plan to maintain blood sugar control safely.
Micronase is not intended for use in children or adolescents unless specifically advised by a doctor. The safety and effectiveness in younger patients have not been established in general practice, so a clinician will determine whether the medicine is appropriate for anyone under 18 years of age.
Glyburide stimulates the beta cells of the pancreas to release more insulin. Insulin helps move glucose from the blood into body tissues where it can be used for energy. By increasing insulin release, Micronase helps lower the amount of glucose that stays in the bloodstream after meals.
The effect of Micronase depends on several factors, including your meal patterns, physical activity level, and how well your kidneys and liver function. In people who have adequate insulin production, the medicine can help regulate blood sugar more consistently. In those with limited insulin production, the response may be different, and alternative therapies may be considered.
Micronase does not replace the need for self-management of diabetes. Diet adherence, regular physical activity, regular monitoring of blood glucose, and routine medical follow-up remain essential parts of diabetes care in Australia. Your clinician will tailor the treatment to your specific situation.
Like other medicines, Micronase can interact with certain foods, illnesses, or other drugs, which may influence how well it works. It is important to tell your clinician about all medicines you take and any health changes you experience while on Micronase.
Your doctor or pharmacist will provide instructions tailored to you. General information can help you understand how to take Micronase safely, but do not change your dosing without professional advice. Take the medicine exactly as prescribed.
Take Micronase with meals to help reduce the risk of low blood sugar. The tablet should be swallowed whole with a full glass of water. Do not crush or chew tablets unless your clinician specifically tells you to.
Keep consistent timing with your meals and medication schedule. If your meal pattern changes, tell your clinician as they may need to adjust the timing or dose. Do not skip meals to avoid low blood sugar; instead, discuss a plan with your healthcare team if you anticipate missed meals or changes in routine.
If you miss a dose, follow the advice given by your clinician or the patient information leaflet. Do not double up doses without medical guidance. If you suspect you have taken too much Micronase, seek medical help promptly or contact a local poison information service for advice.
In case of severe illness with vomiting or diarrhea, your blood sugar may become harder to control. Contact your doctor or pharmacist for advice as soon as possible if you are unwell for an extended period. Do not make changes to your treatment plan without professional input.
Micronase is not suitable for everyone. Do not take this medicine if you have type 1 diabetes or for treatment of diabetic ketoacidosis. The medicine relies on some insulin production, which may not be present in these conditions.
Tell your clinician if you have a history of severe kidney or liver disease. Impaired organ function can affect how you respond to Micronase and may increase the risk of side effects such as low blood sugar. Dose adjustments or alternative therapies may be considered in these cases.
People with a known allergy to glyburide, glibenclamide, or any sulfonylurea should not take Micronase unless advised otherwise by a clinician. Allergic reactions can vary in severity, and your clinician will assess the best course of action if you have prior sensitivities.
Pregnancy and breastfeeding require careful assessment. The safety and suitability of Micronase during pregnancy or while breastfeeding should be discussed with a healthcare professional. Other diabetes treatments may be preferred in certain circumstances, depending on health status and gestational needs.
Older adults may have different responses to this medicine, or an increased risk of low blood sugar. If you are elderly and starting Micronase, your clinician may monitor you more closely and adjust the dose as needed.
Hypoglycaemia (low blood sugar) is a potential risk with Micronase. Symptoms can include sweating, trembling, confusion, dizziness, and sudden hunger. If you notice signs of low blood sugar, treat it promptly following medical guidance, and contact your clinician if symptoms persist or worsen.
Consume Micronase with meals as advised to help reduce the risk of hypoglycaemia. Skipping meals or not eating on a regular schedule can increase the chance of low blood sugar, especially when used with other diabetes medicines.
Inform your doctor about all medicines, vitamins, and supplements you take. Some medicines can interact with glyburide and affect blood sugar control. Your clinician can adjust the treatment plan to avoid harmful interactions.
Alcohol can affect blood sugar levels and may interact with Micronase. Discuss with your clinician whether you should limit or avoid alcohol while taking this medicine.
Medical conditions such as severe infection, trauma, or significant weight loss can change blood sugar needs. If you become unwell, your treatment plan may require adjustment, and you should seek medical advice promptly.
Common side effects of Micronase may include mild stomach discomfort, heartburn, or a feeling of fullness after meals. Some people may notice skin reactions or allergic-type symptoms, though these are not common.
One of the more important potential side effects is low blood sugar. This may present as sweating, shaking, fast heartbeat, confusion, or hunger. If you experience any of these symptoms, check your blood sugar if possible and seek medical advice if symptoms persist or worsen.
Less common side effects can include headache, dizziness, or skin rash. Serious allergic reactions or liver-related concerns are rare but require immediate medical attention if they occur.
If you notice any unusual or persistent symptoms after starting Micronase, contact your clinician or pharmacist. Do not stop the medicine abruptly without medical guidance unless you have been instructed to do so in an urgent situation.
Always report adverse effects to your healthcare provider so they can decide whether a change in therapy is needed. This information helps ensure safe and effective diabetes management for you.
Micronase can interact with other medicines and supplements. It is important to tell your doctor about all medicines you currently take, including over-the-counter drugs and herbal products.
Some medicines may increase the risk of low blood sugar when used with glyburide. Others could change how fast Micronase is cleared from the body, affecting its effectiveness. Your clinician may adjust the dose or change treatment as required.
Insulin or other diabetes medications can increase the risk of hypoglycaemia when used with Micronase. If you use these therapies together, close monitoring is essential and your clinician may adjust the regimen accordingly.
Medications that influence liver enzymes, certain antibiotics, and some antifungals can interact with glyburide. If you start a new medicine, inform your healthcare professional so they can assess possible interactions.
Alcohol is also an interaction risk, since it can affect blood sugar control. Speak with your clinician about safe alcohol use while taking Micronase.
During pregnancy, the safety of Micronase must be assessed by a clinician. In some cases, alternative treatments may be considered depending on gestational status and blood sugar management needed for the mother and baby.
If you are planning pregnancy or become pregnant while taking Micronase, inform your healthcare provider promptly. They can help determine whether continued use is appropriate or if a different therapy should be used.
Breastfeeding while taking Micronase should be discussed with a clinician. Some medicines pass into breast milk, and the risks and benefits need careful consideration to protect the infant and the mother.
Never change dosing during pregnancy or breastfeeding without medical advice. Your clinician will tailor treatment to balance maternal health with potential effects on the baby.
For gestational diabetes specifically, there are guidelines in some settings about alternative treatments; check with your obstetrician or endocrinologist for current recommendations in Australia. Do not rely on general information alone for decisions during pregnancy.
Micronase typically begins to lower blood sugar after the first few days of treatment, but full benefits may take longer to assess. Blood sugar responses vary between people, and your clinician will monitor your progress over weeks. Do not expect immediate results from a single dose.
If you forget a dose, take it as soon as you remember with a meal unless it is almost time for your next scheduled dose. Do not double the dose to make up for the missed one. If you are unsure what to do, contact your clinician or pharmacist for guidance.
Micronase can be used in combination with other diabetes medicines in some cases. The decision depends on your blood sugar levels, kidney function, and the medicines you are already taking. Always follow the plan given by your clinician and report any concerning symptoms promptly.
Seek urgent medical help or follow the local emergency guidance if you have symptoms such as confusion, fainting, severe dizziness, or seizures. If possible, check your blood sugar and treat low blood sugar with a fast-acting carbohydrate as advised by your healthcare team, then contact them for further advice.
Alcohol can affect blood sugar control and may increase the risk of low blood sugar with Micronase. Discuss your drinking habits with your clinician to understand what is safe for you. Moderation or avoidance may be recommended based on your treatment plan.
Yes. Regular blood sugar monitoring is important to ensure the medicine works well and to reduce the risk of hypoglycaemia. Your clinician may also order periodic blood tests to check kidney and liver function, as well as overall diabetes control.
Weight changes can occur with some diabetes medicines, but the extent varies between individuals. Maintaining a healthy diet and regular physical activity as advised by your clinician can help manage weight while using Micronase.
Your doctor will assess how kidney or liver impairment might affect Micronase use. They may adjust dosing or choose a different therapy if necessary. Do not change or stop treatment without medical advice.
Micronase is generally used in adults with type 2 diabetes. In older adults, the risk of low blood sugar may be higher, so clinicians monitor more closely and may adjust treatment accordingly. For younger patients, a clinician must determine suitability on an individual basis.
Micronase helps manage blood sugar levels but it does not cure diabetes. Ongoing lifestyle management and regular medical follow-up are essential for long-term control. If you have questions about prognosis, discuss them with your clinician.
Information in this page draws on general pharmacology and standard outpatient diabetes care guidelines. Always refer to the official product information leaflet for Micronase and consult your healthcare professional for advice tailored to you.
Common reference materials include national and regional guidelines for diabetes management, such as the Australian Medicines Handbook and local therapeutic guidelines. For any uncertainties about your treatment, rely on the advice of your clinician or pharmacist rather than on this page alone.
Official patient information and local regulatory updates provide the most current recommendations regarding prescription requirements and approved indications in Australia. If your situation changes—such as pregnancy, breastfeeding, or new illnesses—seek updated medical advice promptly.
14–21 days. Free from A$279.23 .
5–9 days. A$41.88
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
